Artificial Intelligence Meets Ophthalmology With DIAGNOS
Andre Larente, President of DIAGNOS, explains how artificial intelligence is impacting the field of ophthalmology, enabling for early detection of diabetic retinopathy and other blinding eye diseases. Mr. Larente further explains how his companies technology can detect early signs of non-ocular conditions, including stroke.
About the guest:
André Larente. President, CEO, DIAGNOS Inc.
Mr Larente has been active in the information technology sector for more than 26 years. He has previously held leading management positions with companies such as Siemens, Syscan International, Newbridge Networks, Legent Corporation, Cognos, Tandem Computers and Honeywell Information Systems.
Mr. Larente is the President of the Corporation, his extensive business contacts and experience in the information technology sector, have enabled him to position DIAGNOS for rapid growth.